ProButyrate™ is a Short Chain Fatty Acid (SCFA) dietary supplement specially formulated utilizing the CyLoc™ process to provide strategic SCFA’s in a single molecule form. These SCFA are trapped in a specialized food matrix molecular trap with a release agent that ensures solubility and maximum absorption while minimizing the odor and disagreeable taste of butyric and acetic acid.

ProButyrate™ utilizes the patent-pending DexKey™ release process developed by Al Czap, founder of Thorne Research, that carefully breaks the molecular cage and releases each molecule as needed in the body. Now, thanks to that technology, a caustic, corrosive substance such as butyric acid, with all its documented health benefits becomes a therapeutic reality.

Prior to ProButyrate™, the accepted method of increasing short chain fatty acids such as butyrate was sodium butyrate enema or oral supplementation by butyrate mineral salts, which for most patients are intolerable in taste and smell.

Take 1-3 capsules, two times daily or as recommended by your health-care practitioner.

Serving Size: One Capsule

Amount Per Serving
CyLoc™ alpha dextrin fiber matrix Butyric acid complex* ... 300mg

Ingredients: high and low viscosity hydroxypropyl methylcellulose (sustained release), hypromellose (derived from cellulose) capsule, calcium laurate, leucine, and plant amylase.

*Stabilized Butyric acid as soluble, pure, individual free fatty acid in a hexadextrin matrix molecular trap compounded with DexKey™ release agent (patent pending, Al Czap, Czap R&D, licensed by Tesseract Medical Research, LLC).

CyLoc™ and DexKey™ are trademarks of Tesseract Medical Research, LLC.

Warnings
Tamper Evident: Use only if bottle is sealed.
If pregnant, consult your health-care practitioner before using this product.
Store tightly sealed in a cool, dry place.